PCS
BNTX icon

Personal CFO Solutions’s BioNTech BNTX Stock Holding History

Personal CFO Solutions’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,276
Closed -$329K – 476
2021
Q4 		$329K Sell
1,276
-73
-5% -$20K 0.06% 299
2021
Q3 		$368K Sell
1,349
-816
-38% -$259K 0.08% 235
2021
Q2 		$485K Sell
2,165
-30
-1% -$5.66K 0.1% 189
2021
Q1 		$240K Buy
+2,195
New +$233K 0.05% 331

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
PG
Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Personal CFO Solutions's BNTX Position: Q1 2022 in Review

Personal CFO Solutions sold out of BioNTech (BNTX) in Q1 2022, closing a stake of 1,276 shares — an estimated $329K sold.

Personal CFO Solutions first reported a position in BNTX in Q1 2021 and held it in 4 quarters. The position peaked at $485K in Q2 2021. 287 funds tracked by Wall St. Rank hold BNTX as of Q1 2022.

  • Personal CFO Solutions reported no remaining BioNTech position as of Q1 2022 after selling out during the quarter.
  • Personal CFO Solutions sold 1,276 BioNTech shares in Q1 2022, an estimated $329K.
  • Personal CFO Solutions first reported a position in BioNTech in Q1 2021 and held it in 4 quarters.
  • Personal CFO Solutions's BioNTech position peaked at $485K in Q2 2021.
  • 287 funds tracked by Wall St. Rank held BioNTech as of Q1 2022.

Based on Personal CFO Solutions's 13F filing for Q1 2022, filed 2 May 2022.